Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B

被引：0
作者：
Benoit Guillet
Songkai Yan
Becky Hooper
Douglass Drelich
Jason Steenkamp
Radovan Tomic
Maria Elisa Mancuso
机构：
[1] Hemophilia Treatment Center of Rennes-Bretagne,
[2] University Hospital Center (CHU) Rennes,undefined
[3] CSL Behring,undefined
[4] EVERSANA,undefined
[5] CSL Behring,undefined
[6] IRCCS Humanitas Research Hospital and Humanitas University,undefined
来源：
Advances in Therapy | 2024年 / 41卷
关键词：
Efficacy; Hemophilia B; Matching-adjusted indirect comparisons; Prophylactic treatment; Recombinant factor IX albumin fusion protein; Recombinant factor IX Fc fusion protein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：649 / 658
页数：9
相关论文
共 50 条
  • [21] Biodistribution of the recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in rats
    Herzog, Eva
    Harris, Stephen
    Henson, Claire
    McEwen, Andrew
    Schenk, Sabrina
    Nolte, Marc W.
    Pragst, Ingo
    Dickneite, Gerhard
    Schulte, Stefan
    Zollner, Sabine
    THROMBOSIS RESEARCH, 2014, 133 (05) : 900 - 907
  • [22] Coagulation Factor IX (Recombinant), Albumin Fusion Protein (Albutrepenonacog Alfa; Idelvion®): A Review of Its Use in Haemophilia B
    Lyseng-Williamson, Katherine A.
    DRUGS, 2017, 77 (01) : 97 - 106
  • [23] Discovery of an Orally Effective Factor IX-Transferrin Fusion Protein for Hemophilia B
    Xie, Chen
    Wang, Zhijun
    Su, Yang
    Wang, Jeffrey
    Shen, Wei-Chiang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [24] Prolonged activity of factor IX as a monomeric Fc fusion protein
    Peters, Robert T.
    Low, Susan C.
    Kamphaus, George D.
    Dumont, Jennifer A.
    Amari, John V.
    Lu, Qi
    Zarbis-Papastoitsis, Greg
    Reidy, Thomas J.
    Merricks, Elizabeth P.
    Nichols, Timothy C.
    Bitonti, Alan J.
    BLOOD, 2010, 115 (10) : 2057 - 2064
  • [25] Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial
    Santagostino, Elena
    Martinowitz, Uri
    Lissitchkov, Toshko
    Pan-Petesch, Brigitte
    Hanabusa, Hideji
    Oldenburg, Johannes
    Boggio, Lisa
    Negrier, Claude
    Pabinger, Ingrid
    Prondzinski, Mario von Depka
    Altisent, Carmen
    Castaman, Giancarlo
    Yamamoto, Koji
    Alvarez-Roman, Maria-Teresa
    Voigt, Christine
    Blackman, Nicole
    Jacobs, Iris
    BLOOD, 2016, 127 (14) : 1761 - 1769
  • [26] Recombinant factor IX-Fc fusion protein in severe hemophilia B: Patient-reported outcomes and health-related quality of life
    O'Donovan, Mairead
    Quinn, Eimear
    Johnston, Kate
    Singleton, Evelyn
    Benson, Julie
    O'Mahony, Brian
    Noone, Declan
    Duggan, Cleona
    Gilmore, Ruth
    Ryan, Kevin
    O'Donnell, James S.
    O'Connell, Niamh M.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (07)
  • [27] Validation of the manufacturing process used to produce long-acting recombinant factor IX Fc fusion protein
    McCue, J.
    Osborne, D.
    Dumont, J.
    Peters, R.
    Mei, B.
    Pierce, G. F.
    Kobayashi, K.
    Euwart, D.
    HAEMOPHILIA, 2014, 20 (04) : e327 - e335
  • [28] Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity
    Nummi, V.
    Jouppila, A.
    Lassila, R.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (04) : 359 - 368
  • [29] Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
    Shapiro, Amy D.
    Ragni, Margaret V.
    Valentino, Leonard A.
    Key, Nigel S.
    Josephson, Neil C.
    Powel, Jerry S.
    Cheng, Gregory
    Thompson, Arthur R.
    Goyal, Jaya
    Tubridy, Karen L.
    Peters, Robert T.
    Dumont, Jennifer A.
    Euwart, Donald
    Li, Lian
    Hallen, Bengt
    Gozzi, Peter
    Bitonti, Alan J.
    Jiang, Haiyan
    Luk, Alvin
    Pierce, Glenn F.
    BLOOD, 2012, 119 (03) : 666 - 672
  • [30] Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
    Powell, Jerry S.
    Josephson, Neil C.
    Quon, Doris
    Ragni, Margaret V.
    Cheng, Gregory
    Li, Ella
    Jiang, Haiyan
    Li, Lian
    Dumont, Jennifer A.
    Goyal, Jaya
    Zhang, Xin
    Sommer, Jurg
    McCue, Justin
    Barbetti, Margaret
    Luk, Alvin
    Pierce, Glenn F.
    BLOOD, 2012, 119 (13) : 3031 - 3037
12345